Jun 08–11, 2025 | Whistler Conference Centre, Whistler, BC, Canada
Scientific Organizers:
Michael Ward, Erika L Holzbaur and Sarah L. DeVos
Jun 08–11, 2025 | Whistler Conference Centre, Whistler, BC, Canada
Scientific Organizers:
Michael Ward, Erika L Holzbaur and Sarah L. DeVos
Important Deadlines
Meeting Summary
Neurodegenerative diseases are common but largely untreatable, despite massive investments from both academic and industry sectors. Tackling these diseases will require a collective and integrated effort to address the challenges of identifying, understanding, and translating cellular mechanisms of neurodegeneration into effective therapies.
This meeting will take an innovative approach by assembling speakers and attendees across diverse fields, creating synergy between geneticists, cell biologists, computational biologists, clinicians, and patients to broaden, deepen and integrate our understanding of these diseases. These experts will illustrate how genomics, technology, computational advances, and a focus on convergent cellular pathways will drive innovation and discovery in the field, irrespective of entrenched models. The program will feature new voices in the field, who will generate discussion around new and innovative ideas and directions.
Specifically, the program will:
- Leverage human genetics and genomics to identify convergent and divergent disease pathways;
- Explore new findings in key cellular pathways of neurodegeneration and aging;
- Highlight transformative technologies that enable cell biology at scale in the context of neurodegenerative disease;
- Demonstrate how discoveries are translated into new therapies with an eye towards enhancing inclusion in clinical research and trials;
- Engage with key stakeholders regarding the digital era of neuroscience.
We anticipate that attendees will leave this meeting with a deeper appreciation of how genetic discoveries inform and inspire mechanistic inquiries about cellular disease mechanisms, and how new discoveries and new technologies are driving a revolution in how neurodegenerative diseases are classified and treated.
This conference will be held jointly with the Keystone Symposium on Neuroimmune Interactions: A Systems-Wide Perspective on Whole Organism Physiology to spark innovative cross-disciplinary insights and collaborations towards understanding neuroimmune drivers of neurodegenerative disease and identifying novel therapeutic targets.
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
Federal Funding provided by the National Institutes of Health:
Funding for this conference was made possible (in part) by grant number 1R13NS137710-01 from The National Institute on Neurological Disorders and Stroke (NINDS). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To access the NIH Safe Environment Policy, please click here.
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates